Cargando…

Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in Korean Patients Undergoing Bariatric Surgery

PURPOSE: The number of Korean patients undergoing metabolic surgery for obesity is on the increase. Patients undergoing obesity and metabolic surgery have a body mass index (BMI) ≥30 kg/m(2). In this study, we investigated the prevalence of nonalcoholic fatty liver disease in Korean patients who had...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ki Hyun, Kim, Yoonhong, Seo, Kwang Il, Seo, Kyung Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Metabolic and Bariatric Surgery 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011674/ https://www.ncbi.nlm.nih.gov/pubmed/36926676 http://dx.doi.org/10.17476/jmbs.2022.11.2.63

Ejemplares similares

Short-term outcome of bariatric surgery on nonalcoholic fatty liver disease: a Korean perspective
por: Kim, Ki Hyun, et al.
Publicado: (2022)

Association between the Blautia/Bacteroides Ratio and Altered Body Mass Index after Bariatric Surgery
por: Kim, Yoonhong, et al.
Publicado: (2022)

Association between the Blautia/Bacteroides Ratio and Altered Body Mass Index after Bariatric Surgery
por: Kim, Yoonhong, et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review
por: Głuszyńska, Paulina, et al.
Publicado: (2021)

Hepatic expression of Yin Yang 1 (YY1) is associated with the non-alcoholic fatty liver disease (NAFLD) progression in patients undergoing bariatric surgery
por: Yuan, Xianwen, et al.
Publicado: (2018)

Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort
por: Yoo, Hae Won, et al.
Publicado: (2021)

Trends in the Prevalence of Non-Alcoholic Fatty Liver Disease and Its Future Predictions in Korean Men, 1998–2035
por: Kang, Seo Young, et al.
Publicado: (2020)

Regular Exercise Is Associated with a Reduction in the Risk of NAFLD and Decreased Liver Enzymes in Individuals with NAFLD Independent of Obesity in Korean Adults
por: Bae, Ji Cheol, et al.
Publicado: (2012)

Association between smoking cessation and non-alcoholic fatty liver disease using NAFLD liver fat score
por: Jang, Yun Seo, et al.
Publicado: (2023)

Risk factors of incisional hernia after laparoscopic colorectal surgery with periumbilical minilaparotomy incision: a propensity score matching analysis
por: Kim, Yoonhong, et al.
Publicado: (2022)

Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)
por: Tomasiewicz, Krzysztof, et al.
Publicado: (2018)

Irisin Is Related to Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Kosmalski, Marcin, et al.
Publicado: (2022)

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
por: Rong, Li, et al.
Publicado: (2023)

SREBP-2/PNPLA8 axis improves non-alcoholic fatty liver disease through activation of autophagy
por: Kim, Kwang-Youn, et al.
Publicado: (2016)

Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Saudi Arabia: Systematic Review and Meta-analysis
por: Alenezi, Yusef M, et al.
Publicado: (2023)

In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Kanuri, Giridhar, et al.
Publicado: (2013)

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Carneros, David, et al.
Publicado: (2020)

Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD)
por: Parameswaran, Madhangi, et al.
Publicado: (2021)

What’s New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Kosmalski, Marcin, et al.
Publicado: (2023)

ODP008 Nonalcoholic Fatty Liver Disease (NAFLD) Impacts Weight Loss after Bariatric Surgery
por: Abu-Rumaileh, Mohammed, et al.
Publicado: (2022)

Fatty Liver Index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy
por: Koralegedara, Iresha Sandamali, et al.
Publicado: (2022)

Corrigendum: SREBP-2/PNPLA8 axis improves non-alcoholic fatty liver disease through activation of autophagy
por: Kim, Kwang-Youn, et al.
Publicado: (2016)

Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study
por: Wei, Luyang, et al.
Publicado: (2021)

Non‐alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey
por: Moon, Joon Ho, et al.
Publicado: (2021)

Modeling Non-Alcoholic Fatty Liver Disease (NAFLD) Using “Good-Fit” Genome-Editing Tools
por: Kim, Uijin, et al.
Publicado: (2020)

Prevalence of and risk factors for non-alcoholic fatty liver disease (NAFLD) and fibrosis among young adults in Egypt
por: Tomah, Shaheen, et al.
Publicado: (2021)

Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in Obese Type Two Diabetes Patients in an Endocrine Clinic
por: Shaghouli, Amna Ali, et al.
Publicado: (2021)

The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Savic, Dragana, et al.
Publicado: (2020)

Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery
por: Yang, Andrew, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease and cerebral small vessel disease in Korean cognitively normal individuals
por: Jang, Hyemin, et al.
Publicado: (2019)

Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
por: de Carvalho, Sylene Coutinho Rampche, et al.
Publicado: (2013)

Non-alcoholic fatty liver disease (NAFLD): a tale of fat and sugar?
por: Longato, Lisa
Publicado: (2013)

Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Saeed, Ali, et al.
Publicado: (2017)

Cohort profile: the Trivandrum non-alcoholic fatty liver disease (NAFLD) cohort
por: Chalmers, Jane, et al.
Publicado: (2019)

Non-alcoholic fatty liver disease (NAFLD) and risk of hospitalization for Covid-19.
por: Bramante, Carolyn T., et al.
Publicado: (2020)

The Role of Resolvins, Protectins and Marensins in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Maciejewska-Markiewicz, Dominika, et al.
Publicado: (2021)

Hypercoagulability in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Causes and Consequences
por: Tripodi, Armando, et al.
Publicado: (2022)

Terpenoids: Natural Compounds for Non-Alcoholic Fatty Liver Disease (NAFLD) Therapy
por: Yao, Pengyu, et al.
Publicado: (2022)

Emerging role of nanotechnology in treatment of non-alcoholic fatty liver disease (NAFLD)
por: Moghtadaie, Atie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p6in6n5acbmof375c9ft677h7i